1.Expression and cellular function of long non-coding RNA SFTA1P in non-small cell lung cancer
Mei-yu ZHOU ; Shuai YUAN ; Yin XIANG ; Long WU ; Na WU ; Cheng-ying LI ; Bin XU ; Yao ZHANG ; Tong-jian CAI ; Xiang-yu MA ; Zu-bin YU ; Li BAI ; Jing-yuan YANG ; Ya-fei LI
Chinese Journal of Disease Control & Prevention 2020;24(3):341-347
		                        		
		                        			
		                        			Objective To investigate the expression of long non-coding RNA SFTA1P in non small cell lung cancer ( NSCLC) and its biological function in NSCLC cell lines. Methods Quantitative real time polymerase chain reaction( qRT-PCR) was used to detect the expression of SFTA1P in 18 pairs of NSCLC tissues and adjacent normal tissues. The expression of SFTA1P was detected by qRT-PCR in five different NSCLC cell lines ( A549,SPCA1,H460,H1975 and H1299) and one normal lung epithelial cell line ( HBE) . The overexpression vector of SFTA1P was designed and constructed. The overex- pressed cell line was constructed by transfection,the effects of overexpression of SFTA1P on proliferation, invasion and migration of NSCLC cells were detected by CCK-8 assay and transwell assay. Results The expression of SFTA1P in NSCLC tissues was lower than that of adjacent normal tissues ( t = 2. 158,P = 0. 043) . SFTA1P expression was detected in 5 strains of NSCLC cell lines and normal lung epithelial cell line. The expression of SFTA1P was the lowest in A549 and H460 cell lines ( t = 5. 769,P = 0. 004; t = 5. 772,P= 0. 004) ,and the highest in H1299 and H1975 cell lines ( t = 22. 248,P<0. 001; t = 11. 814,P <0. 001) . SFTA1P overexpression cell models were successfully constructed using A549 and H460 cell lines( all P<0.05) . The overexpression of SFTA1P could inhibit proliferation,invasion and migration of H460 and A549 cells ( ( all P < 0. 05) . Conclusions SFTA1P can affect the biological functions of NSCLC cells by inhibiting the proliferation,migration and invasion. SFTA1P may play a role as a tumor suppressor gene in tumorigenesis and development.
		                        		
		                        		
		                        		
		                        	
2. Pharmacodynamic Evaluation of Tanreqing Inhalation Solution
Ya-yang ZHOU ; Guang-ping ZHANG ; Ling SONG ; Yun-hang GAO ; Hai-jing ZHANG ; Meng MA ; Zhong-xiu ZHANG ; Teng-fei CHEN ; Hong-ping HOU ; Yi-fei YANG ; Ping SU ; Shuang-rong GAO ; Jiang DU ; Zu-guang YE
Chinese Journal of Experimental Traditional Medical Formulae 2019;25(12):71-76
		                        		
		                        			
		                        			 Objective: To clarify the antitussive, expectorant, antipyretic and anti-inflammatory effects of Tanreqing inhalation solution, and provide basis and data support for further research and development of this preparation. Method: The methods of cough induced by ammonia and tracheal phenol red excretion were used to observe the antitussive and expectorant effects of Tanreqing inhalation solution in mice. The fever model of rats was established by intraperitoneal injection of bacterial lipopolysaccharide(LPS) to observe the antipyretic effect of the Tanreqing inhalation solution, the acute pneumonia model of rats was established by atomizing LPS inhalation, and the anti-inflammatory effect of Tanreqing inhalation solution was observed. Result: Tanreqing inhalation solution could reduce the number of coughs in mice induced by ammonia water, increase the amount of phenol red excretion in mouse trachea, decrease the levels of body temperature and its related regulatory factors of prostaglandin E2(PGE2) and cyclic adenosine monophosphate(cAMP) of rats induced by LPS, decrease the white blood cell(WBC) count and the neutrophil ratio(NEUT) in bronchoalveolar lavage fluid(BALF) of rats with LPS-induced acute pneumonia, and reduce the levels of nuclear transcription factor-κB(NF-κB) and interleukin-1β(IL-1β) in lung tissue. Conclusion: Tanreqing inhalation solution has obvious antitussive, expectorant, antipyretic and anti-inflammatory effects, which is worthy of further development and promotion. 
		                        		
		                        		
		                        		
		                        	
3.A study of non-reduced SDS-PAGE purity method of conbercept
Chuan-fei YU ; Feng ZHANG ; Ai-bing LIU ; Ya-fei ZHANG ; Zu-xiu LUO ; Su CHEN ; Xiao KE ; Lan WANG
Acta Pharmaceutica Sinica 2018;53(12):2099-2103
		                        		
		                        			
		                        			 A non-reduced SDS-PAGE purity method for quantitation of conbercept fragments was established based on gel screening, comparison of gel imaging system, linearity range of main band, screening of destaining conditions. The results indicated that the bands could be separated effectively with good clearness and flatness on 4%-15% gradient concentration gel, the peaks of all bands could be separated from baseline using high-distinguishability gel imaging system, the signal intensity of a main band had shown a good linearity with ≤ 3 μg of loading amount, and that the destaining was set as a total of ≤ 3 h with exchanging 100 mL destaining buffer every 60 min. The established non-reduced SDS-PAGE method could demonstrate the purity of conbercept more objectively. After validation, the established non-reduced SDS-PAGE method was submitted to FDA in the form of supplementary materials, which laid a quality basis for the direct entry of conbercept to the clinical Ⅲ study in the United States. 
		                        		
		                        		
		                        		
		                        	
4.Association study of PRDM16 gene polymorphisms with essential hypertension in Xinjiang Uygur population.
Nan-fang LI ; Hong-mei WANG ; Yun-wei BI ; Ling ZHOU ; Xiao-guang YAO ; Zhi-tao YAN ; Fei-ya ZU
Chinese Journal of Medical Genetics 2013;30(6):716-720
OBJECTIVETo assess the association of polymorphisms of PR domain containing 16 gene (PRDM16) with essential hypertension in ethnic Uygur population from Xinjiang, China.
METHODSFunctional regions of the PRDM16 gene were sequenced in 48 Uygur subjects with essential hypertension selected from 480 hypertensive patients and 819 normotensive controls. Representative variations were genotyped with TaqMan-PCR method. Association of variations of PRDM16 gene with hypertension was analyzed.
RESULTSFor the 4 genotyped representative variations (rs2236518, rs2282198, rs2493292 and rs870171), no significant difference in genotype distribution and allele frequencies has been found between the patient and control groups (P>0.05). By ANOVA analysis, none of the polymorphisms was significantly associated with systolic or diastolic blood pressure (P>0.05). Nor was significant difference in haplotypic frequencies between the two groups detected (P>0.05).
CONCLUSIONWe have found no association between the four polymorphisms (rs2236518, rs2282198, rs2493292 and rs870171) of the PRDM16 gene with essential hypertension in ethnic Uygur population from Xinjiang.
Asian Continental Ancestry Group ; genetics ; Blood Pressure ; genetics ; DNA-Binding Proteins ; genetics ; Essential Hypertension ; Female ; Genetic Predisposition to Disease ; Genotype ; Humans ; Hypertension ; genetics ; Male ; Middle Aged ; Polymorphism, Genetic ; Transcription Factors ; genetics
5.Etiology analysis for hospitalized hypertensive patients: 10 years report from the department of hypertension (1999-2008)
Nan-Fang LI ; Li LIN ; Lei WANG ; Xin-Ling WANG ; Fei-Ya ZU ; De-Lian ZHANG ; Gui-Juan CHANG ; Yan-Nin ZHANG ; Ke-Ming ZHOU ; Nuerguli ; Tao LI ; Jun-Li HU ; Jian-Qiong KONG ; Men-Hui WANG ; Qin LUO
Chinese Journal of Cardiology 2010;38(10):939-942
		                        		
		                        			
		                        			Objective To analyze etiology of hospitalized hypertensive patients in the department of hypertension from 1999 to 2008. Methods This retrospective study was performed to analyze the etiology of hospitalized hypertensive patients in department of hypertension and to show the distribution change of hypertension from 1999 to 2008. Results ( 1 ) There were 5867 ( 75. 1% ) patients with essential hypertension and 1942 (24. 9% ) patients with secondary hypertension (SH). (2) The prevalence rate of SH increased significantly during the 10 years (χ2 = 387.621 ,P < 0.001 ) and was higher in 2008 than in 1999 (39. 3% vs. 9. 5% , P < 0. 05 ). The prevalence of obstructive sleep apnea syndrome (OSAS) and primary aldosteronism (PA) in 2008 increased 38.3 and 1.8 times respectively than in 1999 (χ2 =304. 025 ,P <0. 001; χ2 =42. 845 ,P <0. 001 ) and other SH remained unchanged. ( 3 ) The prevalence of PA complicated with OSAS increased significantly in recent five years ( χ2 = 26.376, P <0. 001 ). Incidence of OSAS was 23.9% in PA patients and incidence of PA was 6. 7% in OSAS patients. Conclusions With the insights gained on hypertension mechanism and the development of new diagnostic technology, percent of diagnosed SH increased remarkably in recent years in hospitalized hypertensive patients in our department of hypertension. OSAS and PA are the leading causes of SH.
		                        		
		                        		
		                        		
		                        	
6.Etiology analysis of 628 patients with refractory hypertension
Lei WANG ; Nan-Fang LI ; Ke-Ming ZHOU ; Xin-Ling WANG ; Fei-Ya ZU ; De-Lian ZHANG ; Gui-Juan CHANG ; Yan-Min ZHANG ; Nuerguli ; Meng-Hui WANG
Chinese Journal of Cardiology 2009;37(2):138-141
		                        		
		                        			
		                        			Objective To analyze the etiology of 628 patients with refractory hypertension and to observe the disease distribution with respect to gender and different age groups. Methods In this study,clinical data of 628 refractory hypertensives who hospitalized in our hospital from September 1997 to December 2005 were retrospectively analyzed. Results (1) There were 80.1% (503/628) patients with essential hypertension, 18. 9% (119/628) with secondary hypertension (SH) while diagnosis was not clear in 1.0% (6/628) patients. Renovascular hypertension (33.6%) and obstructive sleep apnea syndrome (23.5%) were the major causes of SH. The highest prevalence rate of endocrine hypertension was primary aldosteronism (13.5%). (2) There were significantly more male patients than female patients with essential hypertension, SH, renal hypertension, obstructive sleep apnea syndrome, rimary aldosteronism while the incidence of pheochromocytoma in female was significantly higher than that in male patients (all P < 0.05).The incidence of renovascular hypertension was similar between male and female patients. (3) SH occurred more often in young patients (33.1%) than in aged patients (13.8%, P < 0.05). Conclusion Our data from this patient cohort showed that SH, especially renovascular hypertension and obstructive sleep apnea syndrome are major causes for refractory hypertension in young patients and primary aldosteromsm was the commonest reason of endocrine hypertension in youth and middle-aged patients with refractory hypertension.
		                        		
		                        		
		                        		
		                        	
7.The relationship between dyslipemia and the polymorphism of angiotensia Ⅱ type 1 receptor gene in hypertensive Kazakkans of Xinjiang
Tao LI ; Nan-Fang LI ; Ling ZHOU ; Xin-Ling WANG ; Fei-Ya ZU ; Jun WANG ; De-Lian ZHANG ; Ke-Ming ZHOU
Chinese Journal of Cardiology 2008;36(10):893-896
		                        		
		                        			
		                        			Objective To investigate the relationship between dyslipidemia and the polymorphism of angiotensin Ⅱ type 1 receptor (AT1R) gene Al166C in hypertensive Kazakans of Xinjiang ares.Methods Polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) methods were used to detect the A1166C polymorphism of AT1R gene of 296 hypertensive and 198 normotensive Kazakans.Biochemical parameters were measured by autochemical emalyzer.Results (1) The TC and LDL-C levels are significantly higher in hypertension group than those in normotensive controls [TC:(4.91±1.19)mmool/L vs.(4.43±1.20) mmol/L;LDL-C:(3.36±1.01) mmol/L vs.(2.94±1.30) mmol/L,P<0.001).(2)In hypertension group,TC and LDL-C are related to A1166C polymorphism of AT1R gene and TC and LDLC of AC carders are significantly higher than AA carriers (P<0.05).Condnsion The dyslipidemia is related to A1166C polymorphism of AT,R gene in hypertensive Kazakans.
		                        		
		                        		
		                        		
		                        	
8.Analysis of etiology of the patients with hypertension from the People's Hospital of Xinjiang Uygur Autonomous Region.
Nan-fang LI ; Lei WANG ; Ke-ming ZHOU ; Xin-ling WANG ; Fei-ya ZU ; De-lian ZHANG ; Yan-min ZHANG ; Gui-juan CHANG
Chinese Journal of Cardiology 2007;35(9):865-868
OBJECTIVETo analyze the etiology of the patients with hypertension from the People's Hospital of Xinjiang Uigur Autonomous Region, and to investigate the distribution of hypertension in gender and different ages.
METHODSFrom September 1997 to December 2005, the data of 4642 patients with hypertension was retrospective studied.
RESULTS(1) Of all the patients, 85.24% were essential hypertension (EH) and 14.76% were secondary hypertension (SH). Higher prevalence of sleep apnea syndrome (42.92%) and anxiety (15.04%) was found in secondary hypertension. The highest prevalence of primary aldosteronism (12.12%) was found in endocrine hypertension. (2) The male patients with hypertension were more than the female ones, and the incidence of EH, sleep apnea syndrome (SAS) and primary aldosteronism was higher in male patients than female ones, and the following was less than female: anxiety, pheochromocytoma and renovascular hypertension. (3) Among the patients with SH, 21.9% were found in youth, and 9.85% in aged.
CONCLUSIONFor the young, SH should be excluded, especially SAS and anxiety should be screened and differentiated. The highest prevalence of endocrine hypertension is primary aldosteronism in young and middle-aged male. The prevalence of pheochromocytoma in female is higher than that of male.
Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; China ; epidemiology ; Female ; Humans ; Hypertension ; epidemiology ; etiology ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; Sex Factors ; Young Adult
9.Long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure.
Dong-mei WANG ; Ya-ling HAN ; Hong-yun ZANG ; Wei-wei ZHOU ; Quan-min JING ; Zu-lu WANG ; Shou-li WANG ; Fei LI
Chinese Journal of Cardiology 2005;33(8):717-719
OBJECTIVETo study the long-term effects and mortality of biventricular pacing therapy in patients with congestive heart failure.
METHODSTwenty-five patients, 18 men and 7 women, aged 34-75 [mean aged of (61.42 +/- 10.36)] years, with a cardiac function of New York Heart Association (NYHA) class III (n = 10) or IV (n = 15) received biventricular pacing therapy from Mar. 2001 to Feb. 2005. The etiologies of heart failure were idiopathic dilated cardiomyopathy (16 cases), hypertensive heart disease (3 cases) and ischemic heart disease (6 cases). Left ventricular end-diastolic dimension (LVEDD) was > 60 mm, Left ventricular ejection fraction (LVEF) was < 0.40 and QRS duration was > 130 ms in all the patients. Heart function parameters were repeatedly measured before and 3 months, 6 months, 1 year, 2 years and 3 years after pacemaker implantation. Mortality was also determined. The average follow up period was (20.88 +/- 11.51) months.
RESULTS(1) Mortality: 5 patients died during follow-up (3 non-cardiac and 1 cardiac sudden death and 1 acute myocardial infarction). (2) The mean 6-min walking distance was increased significantly (P < 0.05) at 3 months to 3 years of follow-up. (3) NYHA class: The cardiac function of all patients improved significantly, with a reduction of mean NYHA class of more than one grade at 3 months to 3 years follow-up. (4) LVEDD: LVEDD reduced significantly (P < 0.05) at 3 months to 3 years follow-up. (5) LVEF: LVEF increased significantly (P < 0.05) at 3 months to 2 years follow-up. LVEF also improved at third year's follow-up, but the difference was not significant statistically.
CONCLUSIONSCardiac resynchronization, a pacemaker-based therapy for heart failure, may enhance quality of life and heart function and reverse LV remodeling. The long-term effects of treatment were stable, leading to the reduction of mortality from advanced heart failure.
Adult ; Aged ; Cardiac Pacing, Artificial ; methods ; Death, Sudden, Cardiac ; Female ; Heart Failure ; mortality ; physiopathology ; therapy ; Humans ; Male ; Middle Aged ; Pacemaker, Artificial ; Survival Rate ; Treatment Outcome
10.A study on the inherited susceptibility of chromosomal damage in peripheral blood lymphocytes among coke oven workers.
Shu-guang LENG ; Yu-xin ZHENG ; Zu-fei PAN ; Yong NIU ; Yu-fei DAI ; Ya-wen WANG ; Wen-zhong ZHANG ; Jun XIAO ; Zhong-xu WANG ; Tao LI ; Feng-sheng HE
Chinese Journal of Preventive Medicine 2004;38(2):94-98
OBJECTIVETo investigate the association between polymorphisms of metabolic enzyme genes and chromosomal damage risk in peripheral blood lymphocytes among coke oven workers.
METHODSOne hundred and fourty-nine coke oven workers and 24 referents without occupational polycyclic aromatic hydrocarbons (PAH) exposure were recruited in this study. Urinary 1-hydroxypyrene levels were measured as the internal dose of PAH exposure. The 6 per 1 000 of micronucleus value was used as the cut-off value to determine whether the individual's chromosomal damage was positive. The genotypes of CYP1A1, GSTM1, GSTT1, GSTP1, CYP2E1, NQO1, NAT2 and mEH genes were determined by PCR-based methods. Multiple logistic regression was used to calculate the adjusted ORs and the 95% CI for the risk of chromosomal damage and to analyze the gene-gene interaction.
RESULTSIn 173 subjects, after adjusting the occupational exposure, age, sex, smoking and drinking status, the subjects with GSTM1 null genotype have significantly higher risk for chromosomal damage than subjects with GSTM1 positive genotype (adjusted OR = 2.01, 95% CI = 1.03 -3.91). Compared with the wild homozygotes at P187S site of NQO1 gene, the variant homozygotes have significantly higher risk for chromosomal damage (adjusted OR = 3.18, 95% CI = 1.18 - 8.62). The subjects with variant allele at H113Y site of mEH gene have significantly lower risk for chromosomal damage (adjusted OR = 0.40, 95% CI = 0.19 - 0.88). No significant associations were found for other gene polymorphisms and chromosomal damage risk. In addition, the gene-gene interactions were also found among GSTM1, NQO1 gene P187S and mEH gene H113Y polymorphisms for the risk of chromosomal damage risk.
CONCLUSIONSignificant associations between genetic polymorphisms in GSTM1, NQO1 and mEH gene and risk for chromosomal damage were found among occupational PAH-exposed workers, which related to the mechanism of PAH carcinogenesis.
Adult ; DNA Damage ; genetics ; Epoxide Hydrolases ; genetics ; Female ; Genetic Predisposition to Disease ; genetics ; Glutathione Transferase ; genetics ; Humans ; Logistic Models ; Lymphocytes ; metabolism ; Male ; Middle Aged ; Multivariate Analysis ; NAD(P)H Dehydrogenase (Quinone) ; genetics ; Occupational Exposure ; Polycyclic Aromatic Hydrocarbons ; poisoning ; Polymorphism, Genetic ; Pyrenes ; analysis ; Risk Factors
            
Result Analysis
Print
Save
E-mail